PURPOSE: To determine whether topically applied latanoprost increases the s
everity of acute herpes simplex keratitis, the rate of recurrence of herpes
keratitis, or both, in the rabbit.
METHODS: To determine the effect on severity of acute herpetic keratitis, t
he corneas of New Zealand white rabbits were infected with either the less-
corticosteroid sensitive McKrae strain or the corticosteroid-sensitive F(MP
)E strain of herpes simplex virus type 1. Rabbits were randomly assigned to
twice-a-day treatment with latanoprost 0.005%, dexamethasone sodium phosph
ate 0.1%, or balanced saline solution within 3 days of infection and evalua
ted daily for up to 13 days after infection. The severity of keratitis was
graded in a masked manner. To determine the effect on recurrences of herpet
ic keratitis, animals infected with McKrae strain herpes simplex virus type
I that survived to day 32 after infection were randomized to treatment wit
h latanoprost 0.005% or balanced saline solution and evaluated for the pres
ence of corneal lesions from postinfection day 32 to day 47.
RESULTS: In the severity studies, treatment of F(MP)E-infected corneas with
latanoprost or dexamethasone significantly worsened herpetic keratitis; by
postinfection day 5, F(MP)E-infected eyes treated with dexamethasone or la
tanoprost demonstrated significantly higher severity scores than the eyes t
reated with balanced saline solution (P = .0001 and .008, respectively). Sc
ores of McKrae-infected corneas treated with latanoprost or dexamethasone w
ere not significantly different from scores of balanced saline solution-tre
ated corneas, In the recurrence study, treatment with latanoprost significa
ntly increased the appearance of clinical recurrences in McKrae-infected ey
es, compared with balanced saline solution treatment (P = .0064).
CONCLUSION: Latanoprost may worsen acute herpetic keratitis in the rabbit e
ye and increase the risk of recurrences in latently infected animals. (C) 1
999 by Elsevier Science Inc. All rights reserved.